Specifically, improved response to alefacept (LFA3-Ig) in patients with recent onset T1D was associated with changing levels of two expanded and hypoproliferative Tex populations which co-expressed TIGIT and KLRG1 and displayed an EOMES gene signature10,12. Here, KLRG1 is linked to type 1 diabetes mellitus.